6 investors discuss why AI is more than just a buzzword in biotech
TechCrunch
DECEMBER 15, 2022
VCs are also increasingly looking for what biotech startups can do with AI beyond just R&D and are wary of companies that use the technology as a marketing tool. The NASDAQ Biotechnology Index peaked in 2021. We also see AI being used in the biologics space, although the technology is used there far earlier.
Let's personalize your content